AEON Biopharma, Inc. Public Float
AEON Biopharma, Inc. (AEON) had Public Float of $8.70 million as of 2025-06-30, per its 10-K filed 2026-03-30.
Financial Statements › Notes › Cover Page
dei:EntityPublicFloat · last filed 2026-03-30
- 2025-06-30: Entity Public Float $8.70M.
- 2024-06-30: Entity Public Float $17.00M.
- 2023-06-30: Entity Public Float $14.20M.
- 2021-06-30: Entity Public Float $332.60M.
| Period end | Entity Public Float |
|---|---|
| 2025-06-30 | $8.70M 10-K · filed 2026-03-30 |
| 2024-06-30 | $17.00M 10-K/A · filed 2025-06-11 |
| 2023-06-30 | $14.20M 10-K/A · filed 2024-05-14 |
| 2021-06-30 | $332.60M 10-K/A · filed 2023-04-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |